ATE348886T1 - Auf zelluläre ziele gerichtete verbindungen - Google Patents

Auf zelluläre ziele gerichtete verbindungen

Info

Publication number
ATE348886T1
ATE348886T1 AT01947636T AT01947636T ATE348886T1 AT E348886 T1 ATE348886 T1 AT E348886T1 AT 01947636 T AT01947636 T AT 01947636T AT 01947636 T AT01947636 T AT 01947636T AT E348886 T1 ATE348886 T1 AT E348886T1
Authority
AT
Austria
Prior art keywords
polypeptide
elements
soluble
membrane
cellular
Prior art date
Application number
AT01947636T
Other languages
English (en)
Inventor
Pamela Jane Elizabeth Rowling
Park Little Chesterfo Research
Geoffrey Paul Smith
Chesterford Little
Simon Hugh Ridley
Original Assignee
Adprotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adprotech Ltd filed Critical Adprotech Ltd
Application granted granted Critical
Publication of ATE348886T1 publication Critical patent/ATE348886T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Steroid Compounds (AREA)
  • Mobile Radio Communication Systems (AREA)
AT01947636T 2000-07-07 2001-07-06 Auf zelluläre ziele gerichtete verbindungen ATE348886T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0016811.2A GB0016811D0 (en) 2000-07-07 2000-07-07 Lipid rafts

Publications (1)

Publication Number Publication Date
ATE348886T1 true ATE348886T1 (de) 2007-01-15

Family

ID=9895288

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01947636T ATE348886T1 (de) 2000-07-07 2001-07-06 Auf zelluläre ziele gerichtete verbindungen

Country Status (8)

Country Link
US (2) US20040043432A1 (de)
EP (1) EP1299537B1 (de)
AT (1) ATE348886T1 (de)
AU (1) AU2001269282A1 (de)
CA (1) CA2415478A1 (de)
DE (1) DE60125364D1 (de)
GB (1) GB0016811D0 (de)
WO (1) WO2002004638A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835545B2 (en) 2000-05-08 2004-12-28 President And Fellows Of Harvard College Methods, products and treatments for diabetes
US7833725B2 (en) 2005-01-06 2010-11-16 President And Fellows Of Harvard College Mass spectrometric methods and products
AU2015202046B2 (en) * 2008-02-15 2017-06-29 Tufts University A humanized model of membrane attack complex (mac) formation on murine retina and compositions, kits and methods for treatment of macular degeneration
CA2843684A1 (en) * 2010-08-13 2012-02-16 Tufts University Compositions, kits and methods for treatment of macular degeneration using soluble membrane-independent cd59 protein
US9068006B2 (en) 2010-08-25 2015-06-30 President And Fellows Of Harvard College Glycated CD59 peptides, their preparation, and uses thereof
US9987235B2 (en) 2013-08-01 2018-06-05 Nicholas L. Abbott Methods and compositions for modifying mucous membranes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0114787B1 (de) * 1983-01-25 1991-09-25 Ciba-Geigy Ag Neue Peptidderivate
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
US5326700A (en) * 1990-11-06 1994-07-05 Eli Lilly And Company DNA sequences encoding t-PA derivatives with cleavable sites
US5856300A (en) * 1994-05-12 1999-01-05 T Cell Sciences, Inc. Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions
CA2184356A1 (en) * 1994-03-03 1995-09-08 Russell P. Rother Terminal complement inhibitor fusion genes and proteins
GB9614871D0 (en) * 1996-07-15 1996-09-04 Smithkline Beecham Plc Compounds
US5776689A (en) * 1996-07-19 1998-07-07 The Regents Of The University Of California Protein recruitment system

Also Published As

Publication number Publication date
US20070031444A1 (en) 2007-02-08
GB0016811D0 (en) 2000-08-30
WO2002004638A1 (en) 2002-01-17
US20040043432A1 (en) 2004-03-04
DE60125364D1 (de) 2007-02-01
EP1299537A1 (de) 2003-04-09
CA2415478A1 (en) 2002-01-17
EP1299537B1 (de) 2006-12-20
AU2001269282A1 (en) 2002-01-21

Similar Documents

Publication Publication Date Title
NZ333722A (en) Soluble fatty acid derived peptide each with binding element more than 5kD as medicaments for disorders associated with inflammation or inappropriate complement activation
ATE281431T1 (de) Resorcin-derivate
BRPI0415448A (pt) método de alvejar populações de célula especìfica empregando-se conjugados de maytansinoid de agente de ligação celular ligados por meio de um ligante não-clivável, os referidos conjugados, e métodos de preparação dos referidos conjugados
DE60219677D1 (de) Wasserlösliche polymerkonjugate von retinoesäure
ATE444082T1 (de) Funktion eines haptoglobin-hämoglobin-rezeptors und anwendungszwecke dafür
UY27098A1 (es) Derivados de indol
WO2005053811A3 (en) Biomolecule partition motifs and uses thereof
ATE485331T1 (de) Thiolselektive wasserlösliche polymerderivate
ATE479383T1 (de) Ph-sensor
HRP20090003T3 (en) Oligopeptides for reducing elevated blood urea concentration
PL1791571T3 (pl) Radiofluorowane peptydy
WO2002024613A3 (en) Resorcinol derivatives
DE50015987D1 (de) Konjugat zur vermittlung eines zell-, kompartimenttanzen
DE60045847D1 (de) Rezeptorbindende konjugate
ITMI20020189A1 (it) Composizione per uso farmaceutico o dietetico per contrastare la caduta dei capelli
ES2175798T3 (es) Cd8 como un inhibidor del sistema inmunitario celular.
ATE348886T1 (de) Auf zelluläre ziele gerichtete verbindungen
WO2003089458A3 (en) Conjugates of membrane translocating agents and pharmaceutically active agents
WO2007095286A3 (en) AQUEOUS PHARMACEUTICAL FORMULATIONS OF ERβ SELECTIVE LIGANDS
TR200102742T2 (tr) Rezorsinol türevleri
YU90301A (sh) Konjugati i postupci za njihovu proizvodnju i njihova upotreba za transport molekula kroz biološke membrane
ATE383384T1 (de) Selbstemulgierende wässrige polyurethandispersionen
GB0220936D0 (en) Modified therapeutic agents
TW200724040A (en) Stable tea concentrates
TR200102741T2 (tr) Resorsinol bileşimi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties